The Breast Cancer Risk Assessment Tool allows health professionals to estimate a woman's risk of developing invasive breast cancer over the next 5 years and up to age 90 (lifetime risk).. The tool uses a woman’s personal medical and reproductive history and the history of breast cancer among her first-degree relatives (mother, sisters, daughters) to estimate absolute breast cancer risk—her. This tool cannot accurately calculate risk for women with a medical history of breast cancer, DCIS or LCIS. Other tools may be more appropriate for women with known mutations in either the BRCA1 or BRCA2 gene, or other hereditary syndromes associated with higher risks of breast cancer. See Other Risk Assessment Tools for more information.
BCRA is an R package that projects absolute risk of invasive breast cancer according to NCI’s Breast Cancer Risk Assessment Tool (BCRAT) algorithm for specified race/ethnic groups and age intervals. The Breast Cancer Surveillance Consortium (BCSC) Risk Calculator was developed and validated in 1.1 million women undergoing mammography across the United States, among whom 18,000 were diagnosed with invasive breast cancer. The BCSC Risk Calculator has been externally validated in the Mayo Mammography Health Study.
Topic: Risk Factors Tags: Medical History There are several breast cancer risk assessment tools that doctors use to calculate a woman’s risk of breast cancer. One of the most well-known is the Gail model, which assesses breast cancer risk based on a series of personal health questions that women and their doctors answer together. IBIS Risk Assessment Tool v8.0b This tool estimates the likelihood of a woman developing breast cancer specifically within 10 years of her current age and over the course of her lifetime. The tool is utilized to inform women and help support the decision making process for genetic counseling and testing.
The cancer Risk Assessment Tool (RAT) is an algorithm that can be used to calculate the absolute risk that a patient has an undiagnosed cancer based on certain risk factors and their current symptoms. The RATs are designed to support GP decision making when deciding which patients require further investigation or referral. The Gail Model for Breast Cancer Risk estimates risk for breast cancer based on demographic and clinical data. The Gail Model is for use in women with no history of breast cancer, DCIS or LCIS. Other tools may be more appropriate for women with known mutations in BRCA1, BRCA2, or other hereditary syndromes associated with breast cancer.